- Home
- NAGE vs HAVA Comparison
NAGE vs HAVA Comparison
Compare NAGE & HAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.03
Company Overview
Basic Information| Metric | NAGE | HAVA |
|---|---|---|
| Founded | 1999 | 2024 |
| Country | United States | South Korea |
| Employees | 117 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.2M | 209.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAGE | HAVA |
|---|---|---|
| Price | $3.03 | $10.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 782.7K | 18.6K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.51 | N/A |
| Revenue Next Year | $14.58 | N/A |
| P/E Ratio | $21.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.87 | $9.90 |
| 52 Week High | $10.52 | $10.17 |
Technical Indicators
Market Signals| Indicator | NAGE | HAVA |
|---|---|---|
| Relative Strength Index (RSI) | 40.71 | 60.80 |
| Support Level | N/A | $9.98 |
| Resistance Level | $3.60 | N/A |
| Average True Range (ATR) | 0.16 | 0.01 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 21.19 | 71.43 |
Price Performance
Historical Comparison NAGE
HAVA
About NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About HAVA Harvard Ave Acquisition Corporation Class A Ordinary Share
Harvard Ave Acquisition Corp is a blank check company.